Forum applauds use, oversight of AI in medicine

Regulators seek harmony in standards for development of high-tech tools

Exploration and cooperation are needed to establish adequate regulations for the use of artificial intelligence and other new and innovative technologies in the medical industry, according to regulatory authorities, who emphasized how essential they are in advancing global health.

Xu Jinghe, deputy commissioner of the National Medical Products Administration, said that the development of medical devices that rely on AI, biomaterials and 3D printing has accelerated in recent years.

Regulatory authorities across the world are experimenting with new tools and methods, rather than sticking to conventional frameworks, in order to ensure the safety and efficacy of innovative medical devices while guiding the development of the industry, he said.